Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | LMNA | P02545 | 4/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9358053 | 1.00 | ALDH1A1 (0.35) | ALDH1A1LMNATSHRKMT2AHSD17B10 | |
| SCHEMBL1628615 | 0.73 | ALDH1A1 (0.37) | ALDH1A1LMNATSHRKMT2AHSD17B10 | |
| SCHEMBL6032804 | 0.71 | — | — | |
| SCHEMBL2710254 | 0.67 | NOS3 (0.32) | ALDH1A1CA1CA2POLBL3MBTL1 | |
| SCHEMBL10399375 | 0.67 | ALDH1A1 (0.37) | ALDH1A1LMNATSHRKMT2AHSD17B10 | |
| SCHEMBL11283022 | 0.67 | ALDH1A1 (0.37) | ALDH1A1LMNATSHRKMT2AHSD17B10 | |
| SCHEMBL1567934 | 0.67 | NOS3 (0.32) | — | |
| SCHEMBL7123770 | 0.67 | ALDH1A1 (0.37) | ALDH1A1LMNATSHRKMT2AHSD17B10 | |
| SCHEMBL10738419 | 0.65 | FNTA (0.38) | ALDH1A1LMNATSHRKMT2AHSD17B10 | |
| SCHEMBL9632348 | 0.65 | PDE4A (0.38) | ALDH1A1LMNATSHRKMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6191286-B1 | REACTING AN AMINO ALKYL DIALKOXYSILANE OR AMINO TRAIALKOXYSILANE AND UNSATURATED ACID ANHYDRIDE TO FORM AN AMICACID SILANE, TREATING AMICACID SILANE WITH A SILYLATING OR ESTERIFYING CAPPING AGENT, HEATING TO FORM IMIDOSILANE | OSI SPECIALTIES INC. | 2001-02-20 | — | — | US | claimed |
| US-5411869-A | For immunoassay of captan by incubation with a labeled captan standard, a captan standard and an antibody to captan and comparing with calibrated standard | OHMICRON CORPORATION (US) | 1995-05-02 | — | — | US | claimed |
| US-11613618-B2 | Porous body, and method for producing porous body | EMAUS KYOTO, INC. (JP) | 2023-03-28 | — | — | US | disclosed |
| US-20210214514-A1 | POROUS BODY, AND METHOD FOR PRODUCING POROUS BODY | EMAUS KYOTO, INC. (JP) | 2021-07-15 | — | — | US | disclosed |
| EP-3789444-A1 | POROUS BODY, AND METHOD FOR PRODUCING POROUS BODY | Emaus Kyoto, Inc. (JP) | 2021-03-10 | — | — | EP | disclosed |
| US-10858491-B2 | Porous particle made of organic polymer, method for producing porous particle made of organic polymer, and block copolymer | KYOTO UNIVERSITY (JP) | 2020-12-08 | — | — | US | disclosed |
| EP-3327071-B1 | POROUS PARTICLE MADE OF ORGANIC POLYMER, METHOD FOR PRODUCING POROUS PARTICLE MADE OF ORGANIC POLYMER | UNIV KYOTO (JP) | 2020-04-29 | — | — | EP | disclosed |
| US-20180223067-A1 | POROUS PARTICLE, METHOD FOR PRODUCING POROUS PARTICLE, AND BLOCK COPOLYMER | KYOTO UNIVERSITY (JP) | 2018-08-09 | — | — | US | disclosed |
| EP-3327071-A1 | POROUS PARTICLE MADE OF ORGANIC POLYMER, METHOD FOR PRODUCING POROUS PARTICLE MADE OF ORGANIC POLYMER, AND BLOCK COPOLYMER | Kyoto University (JP) | 2018-05-30 | — | — | EP | disclosed |
| EP-3327070-A1 | POROUS PARTICLE, METHOD FOR PRODUCING POROUS PARTICLE, AND BLOCK COPOLYMER | Kyoto University (JP) | 2018-05-30 | — | — | EP | disclosed |
| EP-1439182-B1 | Imidosilane compositions | GEN ELECTRIC (US) | 2007-02-14 | — | — | EP | disclosed |
| EP-1439182-A1 | Imidosilane compositions | CROMPTON CORPORATION (US) | 2004-07-21 | — | — | EP | disclosed |
| US-6191286-B1 | REACTING AN AMINO ALKYL DIALKOXYSILANE OR AMINO TRAIALKOXYSILANE AND UNSATURATED ACID ANHYDRIDE TO FORM AN AMICACID SILANE, TREATING AMICACID SILANE WITH A SILYLATING OR ESTERIFYING CAPPING AGENT, HEATING TO FORM IMIDOSILANE | OSI SPECIALTIES INC. | 2001-02-20 | — | — | US | disclosed |
| EP-0982311-A2 | Imidosilane compositions | CK WITCO CORPORATION (US) | 2000-03-01 | — | — | EP | disclosed |
| US-5411869-A | For immunoassay of captan by incubation with a labeled captan standard, a captan standard and an antibody to captan and comparing with calibrated standard | OHMICRON CORPORATION (US) | 1995-05-02 | — | — | US | disclosed |
| US-5411869-A | For immunoassay of captan by incubation with a labeled captan standard, a captan standard and an antibody to captan and comparing with calibrated standard | OHMICRON CORPORATION (US) | 1995-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10858491-B2 | Porous particle made of organic polymer, method for producing porous particle made of organic polymer, and block copolymer | SPOP, NUP205, ATP5PO | ALDH1A1 4832/4885LMNA 2855/4885TSHR 4558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.